Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Rowland W. Rees is active.

Publication


Featured researches published by Rowland W. Rees.


British Journal of Pharmacology | 2001

Y‐27632, an inhibitor of Rho‐kinase, antagonizes noradrenergic contractions in the rabbit and human penile corpus cavernosum

Rowland W. Rees; David J. Ralph; Michael Royle; Salvador Moncada; Selim Cellek

We have examined the effect of an inhibitor of Rho‐kinase, (+)‐(R)‐trans‐4‐(1‐aminoethyl)‐N‐(4‐pyridyl) cyclohexanecarboxamide dihydrochloride monohydrate (Y‐27632), on the contractions elicited by noradrenergic nerve stimulation and by phenylephrine in the human and rabbit penile corpus cavernosum. In both tissues, after treatment with scopolamine (10 μM) and NG‐nitro‐L‐arginine methyl ester (L‐NAME; 300 μM), electrical field stimulation (EFS) elicited noradrenergic contractions. These contractions were inhibited by Y‐27632 in a concentration‐dependent manner. The compound caused concentration‐dependent relaxation of phenylephrine‐contracted tissues, which were treated with scopolamine (10 μM), guanethidine (10 μM) and L‐NAME (300 μM). These results suggest that Rho‐kinase is involved in noradrenergic contractile pathway in the cavernosal smooth muscle of the penis.


BJUI | 2002

The management of low‐flow priapism with the immediate insertion of a penile prosthesis

Rowland W. Rees; Jas Kalsi; Suks Minhas; J. Peters; P. Kell; David J. Ralph

Objective  To evaluate the outcome of patients undergoing the immediate insertion of a penile prosthesis as a treatment for acute low‐flow priapism.


European Urology | 2012

Treatment of Carcinoma In Situ of the Glans Penis with Topical Chemotherapy Agents

Hussain M. Alnajjar; Wayne Lam; Marco Bolgeri; Rowland W. Rees; Matthew Perry; Nicholas A. Watkin

BACKGROUND The use of topical agents in the treatment of carcinoma in situ (CIS) of the penis has been well described in the literature. Previous studies have been limited by small sample size and imprecise end points. OBJECTIVE Establish the response rate of 5-fluorouracil (5-FU) and imiquimod (IQ) in the treatment of penile CIS in a large contemporary series in a supranetwork centre. DESIGN, SETTING, AND PARTICIPANTS Retrospective review of all primary and recurrent cases of penile CIS treated with 5-FU and IQ identified from a prospective database over a 10-yr period. Therapy was standardised in all cases with application to the lesion for 12h every 48 h for 28 d. INTERVENTION 5-FU was the first-line therapy, and IQ was the second-line topical agent. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS The primary end point was defined as complete response (CR; i.e., resolution of lesion), partial response (PR; i.e., lesion reduced in size and or visibility), or no response (NR; ie, no improvement in lesion size and or visibility). The secondary end points included local toxicity and adverse events. No statistical analysis or software was used. RESULTS AND LIMITATIONS A total of 86 patients were diagnosed with CIS of the penis over the 10-yr period. Forty-four (51%) received topical chemotherapy. The mean follow-up was 34 mo. CR to topical chemotherapy was seen in 25 (57%), PR was seen in 6 (13.6%), and NR was seen in the remaining 13 (29.5%) patients. Local toxicity was experienced by 10% of patients, and 12% had an adverse event following application of 5-FU. The retrospective design and short follow-up were the major limitations of this study. CONCLUSIONS Topical chemotherapy agents are moderately effective first-line therapy in the treatment of penile CIS. Toxicity and adverse events were few with our treatment protocol. The issues of long-term surveillance and assessment of partial responders remain a challenge. Topical chemotherapy should remain a first-line treatment option for penile CIS.


Journal of Pediatric Urology | 2014

Priapism in children: a comprehensive review and clinical guideline

James F. Donaldson; Rowland W. Rees; Henrik A. Steinbrecher

OBJECTIVE We review the English literature between 1980 and 2013 and summarize the clinical classification, aetiology, physiology, and pathophysiology of paediatric priapism. We propose a clinical guideline for the management of priapism in children. PATIENTS Male patients aged ≤ 18 years. RESULTS Priapism, a prolonged penile erection lasting >4 h, is a rare condition in childhood. There are 3 widely accepted types of priapism: 1) ischaemic priapism, the commonest type seen in children; 2) stuttering priapism, recurrent, self-limiting prolonged erections; and 3) non-ischaemic priapism, rare in children, usually due to trauma. Neonatal priapism has also been described. Ischaemic priapism is a urological emergency causing fibrosis of the corpora cavernosa, subsequent erectile dysfunction and penile disfigurement. The commonest causes of priapism in children are sickle cell disease (65%), leukaemia (10%), trauma (10%), idiopathic (10%), and pharmacologically induced (5%). CONCLUSIONS Priapism in children must be assessed urgently. Rapid resolution of ischaemic priapism prevents permanent cavernosal structural damage and is associated with improved prognosis for potency later in life. Stuttering priapism requires careful counselling for episodic management. Chronic prophylaxis may be obtained using α-adrenergic sympathomimetics, phosphodiesterase type 5 inhibitors and, in sickle cell disease, hydroxyurea. Non-ischaemic and neonatal priapism may generally be treated less urgently.


Expert Opinion on Investigational Drugs | 2002

A Rho-kinase inhibitor, soluble guanylate cyclase activator and nitric oxide-releasing PDE5 inhibitor: novel approaches to erectile dysfunction.

Selim Cellek; Rowland W. Rees; Jas Kalsi

Approximately 50% of men aged over 40 suffer from male erectile dysfunction. Treatment options have widened since the launch of the phosphodiesterase type 5 (PDE5) inhibitor, sildenafil citrate (Viagra™). However, a certain portion of the patient population, such as diabetics, do not gain significant benefit from PDE5 inhibitors, possibly due to a lack of endogenous nitric oxide. Therefore, new treatment modalities based on the absence of endogenous nitric oxide have been developed. Among them are Rho-kinase inhibitors, soluble guanylate cyclase activators and nitric oxide-releasing PDE5 inhibitors. The available data concerning these compounds will be summarised and their therapeutic potential for male erectile dysfunction will be discussed.


The Scientific World Journal | 2008

Paraganglioma of the spermatic cord: case report and review of the literature.

G. Garaffa; Asif Muneer; A. Abdel Raheem; Alex Freeman; David J. Ralph; Suks Minhas; Rowland W. Rees

Paragangliomas rarely involve the genitourinary tract. We present a case of a paraganglioma arising from the spermatic cord and review the literature on the topic.


The Scientific World Journal | 2009

Case Study: The Surgical Management of Angiokeratoma Resulting from Radiotherapy for Penile Cancer

Rowland W. Rees; Alex Freeman; Peter Malone; Giulio Garaffa; Asif Muneer; Suks Minhas

Angiokeratoma is a rare, benign skin lesion and a recognised complication of radiation therapy. Here we describe a case of extensive angiokeratoma of the groin and external genitalia resulting from external beam radiation to that area in a patient with penile carcinoma. Furthermore, we outline the management of this problem by surgical reconstruction.


BJUI | 2018

British Association of Urological Surgeons (BAUS) consensus document for the management of male genital emergencies ‐ testicular trauma

Marc Lucky; Gareth Brown; Trevor J. Dorkin; Richard Pearcy; Majid Shabbir; Chitranjan J. Shukla; Rowland W. Rees; Duncan J. Summerton; Asif Muneer; Genitourethral Surgery

Male genital emergencies relating to the penis and scrotum are rare and require prompt investigation and surgical intervention. Clinicians are often unfamiliar with the management of these conditions and may not work in a specialist centre with on‐site expertise in genitourethral surgery. A series of consensus statements have been developed by an expert consensus comprising British Association of Urological Surgeons (BAUS) Section of Andrology and Genitourethral Surgery together with experts from units throughout the UK. Testicular trauma requires prompt investigation and treatment in order to prevent the development of subfertility or hypogonadism. This series of consensus statements provide guidance for UK practice.


BJUI | 2018

BAUS consensus document for the management of male genital emergencies: priapism

Asif Muneer; Gareth Brown; Trevor J. Dorkin; Marc Lucky; Richard Pearcy; Majid Shabbir; Chitranjan J. Shukla; Rowland W. Rees; Duncan J. Summerton

Male genital emergencies relating to the penis and scrotum are rare and require prompt investigation and surgical intervention. Clinicians are often unfamiliar with the management of these conditions and may not work in a specialist centre with on‐site expertise in genitourethral surgery. A series of consensus statements have been developed by an expert consensus committee comprising members of the BAUS Section of Andrology and Genitourethral Surgery together with experts from urology units throughout the UK. Priapism requires prompt assessment and treatment and these consensus statements provide guidance for UK practice.


BJUI | 2018

BAUS Consensus Document for the Management of Male Genital Emergencies - Penile Fracture

Rowland W. Rees; Gareth Brown; Trevor J. Dorkin; Marc Lucky; Richard Pearcy; Majid Shabbir; Chitranjan J. Shukla; Duncan J. Summerton; Asif Muneer

Male genital emergencies relating to the penis and scrotum are rare and require prompt investigation and surgical intervention. Clinicians are often unfamiliar with the management of these conditions and may not work in a specialist centre with on‐site expertise in genitourethral surgery. The aim of these consensus statements is to provide best practice guidance for urological surgeons based in the UK which are developed by an expert consensus. Penile fracture is a rare emergency and in most cases requires prompt exploration and repair to prevent erectile dysfunction and penile curvature.

Collaboration


Dive into the Rowland W. Rees's collaboration.

Top Co-Authors

Avatar

David J. Ralph

University College Hospital

View shared research outputs
Top Co-Authors

Avatar

Suks Minhas

University College Hospital

View shared research outputs
Top Co-Authors

Avatar

Asif Muneer

University College Hospital

View shared research outputs
Top Co-Authors

Avatar

Selim Cellek

University College London

View shared research outputs
Top Co-Authors

Avatar

Alex Freeman

University College Hospital

View shared research outputs
Top Co-Authors

Avatar

Duncan J. Summerton

University Hospitals of Leicester NHS Trust

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jas Kalsi

University College London

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge